Event snippet :

ABOUT US

  • One of the longest, established, privately held biotech companies, founded in 1978.

  • Leading global provider of high-quality raw materials to the in-vitro diagnostic industry and research laboratories.

  • ISO 13485:2016 registered.

KEY CAPABILITIES

  • First to market proteins and monoclonal antibodies for the new emerging viruses, eg. Dengue, Chikungunya and Zika, Sars, Covid -19 and VEEV virus.

  • Wide range of well-established products for chemiluminscence, ELISA, lateral flow and other immunoassay formats.
     

  • Custom manufacture of antibodies and recombinant antigens under ISO 13485:2016 conditions

OUR GOAL

  • To maintain our position as the leading global provider of high-quality and esoteric biological raw materials to the in-vitro diagnostic industry.

  • To enable our customers to bring ground-breaking technology to the market faster allowing cost-effective and efficient patient management at the point of impact.

Aalto Bio Reagents Ltd,

Church Lane, Rathfarnham Village,

Dublin D14 RK22, Ireland. 


Tel: +353-1-4900685

Fax +353-1-4900122

E-mail: info@aaltobioreagents.com

Web: www.aaltobioreagents.com

  • Follow Aalto Bio Reagents on Twitter
  • slideshare
  • LinkedIn Social Icon

© 2018 Aalto Bio Reagents